Bostrycin inhibits proliferation of human lung carcinoma A549 cells via downregulation of the PI3K/Akt pathway

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Chen, Wei Sheng ^a   Hou, Jun Na ^a   Guo, Yu Biao ^a   Yang, Hui Ling ^b   Xie, Can Mao ^a   Lin, Yong Cheng ^a   She, Zhi Gang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BOSTRYCIN; MICRORNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P100ALPHA; PROTEIN P27; UNCLASSIFIED DRUG; ANTHRAQUINONE DERIVATIVE; CYCLIN DEPENDENT KINASE INHIBITOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; ADENOCARCINOMA; BIOSYNTHESIS; CELL CYCLE; DRUG EFFECT; LUNG TUMOR; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADENOCARCINOMA; ANTHRAQUINONES; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; DOWN-REGULATION; HUMANS; LUNG NEOPLASMS; MICRORNAS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 79551687167     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-17     Document Type: Article

References (28)

1. Targeting Growth Factors in Lung Cancer. PS Hodkinson A Mackinnon T Sethi, C (Pubitemid 351685528)
2. Marine pharmacology in 2005-2006: antitumour and cytotoxic compounds. AM Mayer KR Gustafson, Eur J Cancer 2008 44 2357 2387 10.1016/j.ejca.2008.07.001 18701274
3. Inhibitory effects of marine fungal metabolites from the South China Sea on prostate cancer cell line DU-145. W Lin LK Fang JW Liu WQ Cheng M Yun HL Yang, International Journal of Internal Medicine 2008 35 562 564
4. Effects of marine fungal metabolites (1386A) from the South China Sea on proliferation, apoptosis and membrane potential of gastric cancer cell line MCG-803. CQ Chen LK Fang JW Liu JW Zhang GG Yang W Yang, Chinese Journal of Pathophysiology 2010 26 1908 1912
5. Inhibitors of the PI3-kinase/Akt pathway induce mitotic catastrophe in non-small cell lung cancer cells. TH Hemstrom M Sandstrom B Zhivotovsky, Int J Cancer 2006 119 1028 1038 10.1002/ijc.21927 16570272 (Pubitemid 44116909)
6. The farnesyltransferase inhibitor Lonafarnib induces growth arrest or apoptosis of human lung cancer cells without downregulation of Akt. SY Sun Z Zhou R Wang H Fu FR Khuri, Cancer Biol Ther 2004 3 1092 1098 discussion 1099-1101 10.4161/cbt.3.11.1176 15467440 (Pubitemid 41350990)
7. Perturbations of the AKT signaling pathway in human cancer. DA Altomare JR Testa, Oncogene 2005 24 7455 7464 10.1038/sj.onc.1209085 16288292 (Pubitemid 41637985)
8. Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells. J Tsurutani SS Castillo J Brognard CA Granville C Zhang JJ Gills J Sayyah PA Dennis, Carcinogenesis 2005 26 1182 1195 10.1093/carcin/bgi072 15790591 (Pubitemid 41417895)
9. Critical involvement of the phosphatidylinositol 3-kinase/Akt pathway in anchorage-independent growth and hematogeneous intrahepatic metastasis of liver cancer. K Nakanishi M Sakamoto J Yasuda M Takamura N Fujita T Tsuruo S Todo S Hirohashi, Cancer Res 2002 62 2971 2975 12019180 (Pubitemid 34525787)
10. Prognostic significance of clinical factors and Akt activation in patients with bronchioloalveolar carcinoma. J Tsurutani SM Steinberg M Ballas M Robertson J LoPiccolo H Soda S Kohno V Egilsson PA Dennis, Lung Cancer 2007 55 115 121 10.1016/j.lungcan.2006.09.026 17097759 (Pubitemid 46038882)
11. Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis. JM Tang QY He RX Guo XJ Chang, Lung Cancer 2006 51 181 191 10.1016/j.lungcan.2005.10.003 16324768
12. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. S Dimmeler I Fleming B Fisslthaler C Hermann R Busse AM Zeiher, Nature 1999 399 601 605 10.1038/21224 10376603
13. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. PJ Coffer J Jin JR Woodgett, Biochem J 1998 335 Pt 1 1 13 9742206 (Pubitemid 28477043)
14. Regulation of cell death protease caspase-9 by phosphorylation. MH Cardone N Roy HR Stennicke GS Salvesen TF Franke E Stanbridge S Frisch JC Reed, Science 1998 282 1318 1321 10.1126/science.282.5392.1318 9812896 (Pubitemid 28524494)
15. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. A Brunet A Bonni MJ Zigmond MZ Lin P Juo LS Hu MJ Anderson KC Arden J Blenis ME Greenberg, Cell 1999 96 857 868 10.1016/S0092-8674(00) 80595-4 10102273 (Pubitemid 29165088)
16. Induction of NF-kappaB by the Akt/PKB kinase. LP Kane VS Shapiro D Stokoe A Weiss, Curr Biol 1999 9 601 604 10.1016/S0960-9822(99)80265-6 10359702
17. Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. RC Muise-Helmericks HL Grimes A Bellacosa SE Malstrom PN Tsichlis N Rosen, J Biol Chem 1998 273 29864 29872 10.1074/jbc.273.45.29864 9792703 (Pubitemid 28510001)
18. Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer. LJ Miao J Wang SS Li YM Wu YJ Wu XC Wang, Ai Zheng 2006 25 1216 1220 17059763
19. Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells. Q Chen S Ganapathy KP Singh S Shankar RK Srivastava, PLoS One 2010 5 15288 10.1371/journal.pone.0015288 21179458
20. MicroRNA in lung cancer. SP Nana-Sinkam MW Geraci, J Thorac Oncol 2006 1 929 931 10.1097/01243894-200611000-00002 17409974 (Pubitemid 47181358)
21. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. N Yanaihara N Caplen E Bowman M Seike K Kumamoto M Yi RM Stephens A Okamoto J Yokota T Tanaka GA Calin CG Liu CM Croce CC Harris, Cancer Cell 2006 9 189 198 10.1016/j.ccr.2006.01.025 16530703 (Pubitemid 43357945)
22. Suppression of non-small cell lung tumor development by the let-7 microRNA family. MS Kumar SJ Erkeland RE Pester CY Chen MS Ebert PA Sharp T Jacks, Proc Natl Acad Sci USA 2008 105 3903 3908 10.1073/pnas.0712321105 18308936 (Pubitemid 351723497)
23. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. M Crawford E Brawner K Batte L Yu MG Hunter GA Otterson G Nuovo CB Marsh SP Nana-Sinkam, Biochem Biophys Res Commun 2008 373 607 612 10.1016/j.bbrc.2008. 06.090 18602365
24. MicroRNA signature predicts survival and relapse in lung cancer. SL Yu HY Chen GC Chang CY Chen HW Chen S Singh CL Cheng CJ Yu YC Lee HS Chen TJ Su CC Chiang HN Li QS Hong HY Su CC Chen WJ Chen CC Liu WK Chan KC Li JJ Chen PC Yang, Cancer Cell 2008 13 48 57 10.1016/j.ccr.2007.12.008 18167339 (Pubitemid 350309743)
25. Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. A Markou EG Tsaroucha L Kaklamanis M Fotinou V Georgoulias ES Lianidou, Clin Chem 2008 54 1696 1704 10.1373/clinchem.2007.101741 18719201
26. EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. GJ Weiss LT Bemis E Nakajima M Sugita DK Birks WA Robinson M Varella-Garcia PA Bunn Jr J Haney BA Helfrich H Kato FR Hirsch WA Franklin, Ann Oncol 2008 19 1053 1059 10.1093/annonc/mdn006 18304967 (Pubitemid 351796329)
27. The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. C Guo JF Sah L Beard JK Willson SD Markowitz K Guda, Genes Chromosomes Cancer 2008 47 939 946 10.1002/gcc.20596 18663744
28. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. B Kefas J Godlewski L Comeau Y Li R Abounader M Hawkinson J Lee H Fine EA Chiocca S Lawler B Purow, Cancer Res 2008 68 3566 3572 10.1158/0008-5472.CAN-07-6639 18483236